Align Technology Inc
ALGNNasdaqCIK 1097149HealthcareFiscal year ends Dec 31
Reports and events: 297 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-3116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001097149-26-000065 |
| 2026-08-0516:08 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001097149-26-000060 |
| 2026-07-2916:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-26-000056 |
| 2026-07-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-26-000054 |
| 2026-07-0920:29 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001097149-26-000050 |
| 2026-06-2221:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-26-000048 |
| 2026-05-2016:28 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001097149-26-000042 |
| 2026-05-0616:43 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001097149-26-000040 |
| 2026-05-0119:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-26-000036 |
| 2026-04-2916:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-26-000033 |
| 2026-04-0716:05 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001097149-26-000023 |
| 2026-02-2716:06 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001097149-26-000014 |
| 2026-02-2616:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001097149-26-000010 |
| 2026-02-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-26-000006 |
| 2025-11-0516:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001097149-25-000079 |
| 2025-10-2916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-25-000075 |
| 2025-09-1817:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001097149-25-000069 |
| 2025-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001097149-25-000064 |
| 2025-08-0520:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-25-000059 |
| 2025-07-3016:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-25-000055 |
| 2025-07-0216:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001097149-25-000050 |
| 2025-05-2117:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001097149-25-000040 |
| 2025-05-0817:14 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001097149-25-000034 |
| 2025-05-0609:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-25-000030 |
| 2025-04-3016:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-25-000028 |
| 2025-04-0816:34 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001097149-25-000021 |
| 2025-02-2807:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001097149-25-000012 |
| 2025-02-2520:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-25-000008 |
| 2025-02-0516:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-25-000005 |
| 2024-11-0516:09 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001097149-24-000060 |
| 2024-10-2520:37 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-24-000056 |
| 2024-10-2316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-24-000053 |
| 2024-08-0216:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001097149-24-000049 |
| 2024-07-2416:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-24-000045 |
| 2024-05-2217:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001097149-24-000037 |
| 2024-05-0316:25 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001097149-24-000033 |
| 2024-04-2618:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-24-000029 |
| 2024-04-2416:02 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-24-000026 |
| 2024-04-0916:06 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0001097149-24-000018 |
| 2024-02-2817:13 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001097149-24-000011 |
| 2024-01-3116:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-24-000007 |
| 2024-01-1717:43 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001097149-24-000003 |
| 2023-12-0516:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001097149-23-000091 |
| 2023-11-0618:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-23-000087 |
| 2023-11-0316:03 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001097149-23-000082 |
| 2023-10-2721:23 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001097149-23-000078 |
| 2023-10-2516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001097149-23-000075 |
| 2023-09-0616:03 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001097149-23-000070 |
| 2023-08-2420:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001097149-23-000064 |
| 2023-08-0416:07 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001097149-23-000059 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.